BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 31351488)

  • 1. Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study.
    Henrotin Y; Malaise M; Wittoek R; de Vlam K; Brasseur JP; Luyten FP; Jiangang Q; Van den Berghe M; Uhoda R; Bentin J; De Vroey T; Erpicum L; Donneau AF; Dierckxsens Y
    Arthritis Res Ther; 2019 Jul; 21(1):179. PubMed ID: 31351488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of
    Wang Z; Jones G; Winzenberg T; Cai G; Laslett LL; Aitken D; Hopper I; Singh A; Jones R; Fripp J; Ding C; Antony B
    Ann Intern Med; 2020 Dec; 173(11):861-869. PubMed ID: 32926799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
    Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study.
    Krupka E; Jiang GL; Jan C
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1599-1607. PubMed ID: 31351965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial.
    Srivastava S; Saksena AK; Khattri S; Kumar S; Dagur RS
    Inflammopharmacology; 2016 Dec; 24(6):377-388. PubMed ID: 27761693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial.
    Madhu K; Chanda K; Saji MJ
    Inflammopharmacology; 2013 Apr; 21(2):129-36. PubMed ID: 23242572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized, Double Blind, Placebo Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Curene® versus Placebo in Reducing Symptoms of Knee OA.
    Panda SK; Nirvanashetty S; Parachur VA; Mohanty N; Swain T
    Biomed Res Int; 2018; 2018():5291945. PubMed ID: 30498758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study.
    McAlindon TE; Schmidt U; Bugarin D; Abrams S; Geib T; DeGryse RE; Kim K; Schnitzer TJ
    Osteoarthritis Cartilage; 2018 Oct; 26(10):1291-1299. PubMed ID: 29753118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial.
    Henrotin Y; Berenbaum F; Chevalier X; Marty M; Richette P; Rannou F
    BMC Musculoskelet Disord; 2017 May; 18(1):222. PubMed ID: 28549430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
    JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, randomized, double-blinded, double-dummy and multicenter phase IV clinical study comparing the efficacy and safety of PG201 (Layla) and SKI306X in patients with osteoarthritis.
    Ha CW; Park YB; Min BW; Han SB; Lee JH; Won YY; Park YS
    J Ethnopharmacol; 2016 Apr; 181():1-7. PubMed ID: 26821189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial.
    Petterson SC; Plancher KD
    Knee Surg Sports Traumatol Arthrosc; 2019 Jun; 27(6):1992-2002. PubMed ID: 30159738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis.
    Zeng L; Yu G; Hao W; Yang K; Chen H
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailable turmeric extract for knee osteoarthritis: a randomized, non-inferiority trial versus paracetamol.
    Singhal S; Hasan N; Nirmal K; Chawla R; Chawla S; Kalra BS; Dhal A
    Trials; 2021 Jan; 22(1):105. PubMed ID: 33516238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of E-OA-07 in moderate to severe symptoms of osteoarthritis: a double-blind randomized placebo-controlled study.
    Kulkarni MP; Shakeel A; Shinde BS; Rosenbloom RA
    Am J Ther; 2011; 18(2):170-7. PubMed ID: 21317618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee.
    Singh K; Sharma R; Rai J
    Int J Rheum Dis; 2012 Feb; 15(1):69-77. PubMed ID: 22324949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity, structural severity and their combination on the efficacy of viscosupplementation in patients with knee osteoarthritis.
    Conrozier T; Eymard F; Chouk M; Chevalier X
    BMC Musculoskelet Disord; 2019 Aug; 20(1):376. PubMed ID: 31421686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
    Blotman F; Maheu E; Wulwik A; Caspard H; Lopez A
    Rev Rhum Engl Ed; 1997 Dec; 64(12):825-34. PubMed ID: 9476272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee.
    Tiseo PJ; Kivitz AJ; Ervin JE; Ren H; Mellis SJ
    Pain; 2014 Jul; 155(7):1245-1252. PubMed ID: 24686255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Placebo-Controlled Double-Blind Study Demonstrates the Clinical Efficacy of a Novel Herbal Formulation for Relieving Joint Discomfort in Human Subjects with Osteoarthritis of Knee.
    Karlapudi V; Prasad Mungara AVV; Sengupta K; Davis BA; Raychaudhuri SP
    J Med Food; 2018 May; 21(5):511-520. PubMed ID: 29708818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.